Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,127 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

NCT01578889

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Penn Prevention CRS Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults

NCT01479296

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
View Trial Details
Completed

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

NCT01438606

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Penn Prevention CRS Philadelphia, Pennsylvania, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
View Trial Details
Completed

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

NCT01571960

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
View Trial Details
Completed

Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults

NCT01095224

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults

NCT02207920

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
View Trial Details
Completed

Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults

NCT02431767

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details

Related conditions